SCHEMBL6996866

SCHEMBL6996866

O=[N+]([O-])c1cc2c(cc1O)C1CCC2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 3/20 0.42
MAPK1 P28482 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HSP90AA1 P07900 1/20 0.41
STS P08842 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP3A4 P08684 1/20 0.39
ALDH5A1 P51649 1/20 0.39
ABAT P80404 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14524424 0.82 SIRT6 (0.43) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL14003853 0.79 CHRNB4 (0.41) MAPK1ALDH1A1HPGDTSHRL3MBTL1
SCHEMBL14364782 0.79 CHRNB4 (0.41) MAPK1ALDH1A1HPGDTSHRL3MBTL1
SCHEMBL6392586 0.76 CYP2C9 (0.35) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL4406652 0.76 ESR1 (0.34) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL11835122 0.73 GPR35 (0.60) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL19084233 0.73 GPR35 (0.43) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL14411434 0.72 MAPT (0.44) ALDH1A1TSHRALOX15L3MBTL1HSP90AA1
SCHEMBL19899529 0.71 GPR35 (0.55) GPR35MAPK1ALDH1A1HPGDTP53
SCHEMBL6981624 0.71 MAPK1 (0.55) GPR35MAPK1ALDH1A1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed